Page 264 - IJB-9-4

International Journal of Bioprinting Applications of 3D printing in aging

74. Zhang D, Pekkanen-Mattila M, Shahsavani M, et al., 2014, system in the investigation of CDNF as a treatment for
A 3D Alzheimer’s disease culture model and the induction Parkinson’s disease.
of P21-activated kinase mediated sensing in iPSC derived
neurons. Biomaterials, 35:1420–1428. https://www.renishaw.com.cn/zh/renishaw-announces-
completion-of-clinical-trial-extension-study-using-its-
https://doi.org/10.1016/j.biomaterials.2013.11.028 innovative-drug-delivery-system-in-the-investigation-of-
75. Kelava I, Lancaster MA, 2016, Stem cell models of human cdnf-as-a-treatment-for-parkinsons-disease--45590
brain development. Cell Stem Cell, 18:736–748. 85. Zhou Y, Jenkins ME, Naish MD, et al., 2018, in Development
https://doi.org/10.1016/j.stem.2016.05.022 of a Wearable Tremor Suppression Glove. in 7th IEEE
International Conference on Biomedical Robotics and
76. Kato-Negishi M, Morimoto Y, Onoe H, et al., 2013, Biomechatronics (BIOROB), 640–645.
Millimeter-sized neural building blocks for 3D heterogeneous
neural network assembly. Adv Healthc Mater, 2:1564–1570. 86. Farshid SP, Eric W, Shwetak P, et al., 2019, AuraRing:
Precise Electromagnetic Finger Tracking. in 32nd Annual
https://doi.org/10.1002/adhm.201300052 ACM Symposium on User Interface Software and Technology
77. Jo J, Xiao Y, Sun AX, et al., 2016, Midbrain-like organoids (UIST), 122–124.
from human pluripotent stem cells contain functional 87. Wu YY, Acharya D, Xu C, et al., 2018, Custom-fit three-
dopaminergic and neuromelanin-producing neurons. Cell dimensional-printed BiPAP mask to improve compliance
Stem Cell, 19:248–257.
in patients requiring long-term noninvasive ventilatory
https://doi.org/10.1016/j.stem.2016.07.005 support. J Med Devices Trans ASME, 12(3):031003.
78. Marton RM, Pașca SP, 2020, Organoid and assembloid https://doi.org/10.1115/1.4040187
technologies for investigating cellular crosstalk in human 88. LeBoff MS, Greenspan SL, Insogna KL, et al., 2022, The
brain development and disease. Trends Cell Biol, 30:133–143. clinician’s guide to prevention and treatment of osteoporosis.

https://doi.org/10.1016/j.tcb.2019.11.004 Osteoporos Int, 33:2049–2102.
79. Gu Q, Tomaskovic-Crook E, Lozano R, et al., 2016, https://doi.org/10.1007/s00198-021-05900-y
Functional 3D neural mini-tissues from printed gel-based 89. Mundy GR, 2007, Osteoporosis and inflammation. Nutr
bioink and human neural stem cells. Adv Healthc Mater, Rev, 65:S147–S151.
5:1429–1438.
https://doi.org/10.1111/j.1753-4887.2007.tb00353.x
https://doi.org/10.1002/adhm.201600095
90. Reid IR, 2020, A broader strategy for osteoporosis
80. Zhou X, Cui H, Nowicki M, et al., 2018, Three-dimensional- interventions. Nat Rev Endocrinol, 16:333–339.
bioprinted dopamine-based matrix for promoting neural
regeneration. ACS Appl Mater Interfaces, 10:8993–9001. https://doi.org/10.1038/s41574-020-0339-7
https://doi.org/10.1021/acsami.7b18197 91. Słupski W, Jawień P, Nowak B, 2021, Botanicals in
postmenopausal osteoporosis. Nutrients, 13(5):1609.
81. Dong M, Wang X, Chen XZ, et al., 2020, 3D-printed
soft magnetoelectric microswimmers for delivery and https://doi.org/10.3390/nu13051609
differentiation of neuron-like cells. Adv Funct Mater, 92. Kendler DL, Marin F, Zerbini CAF, et al., 2018, Effects of
30:1910323. teriparatide and risedronate on new fractures in post-
menopausal women with severe osteoporosis (VERO): A
https://doi.org/10.1002/adfm.201910323
multicentre, double-blind, double-dummy, randomised
82. Gultekin HE, Tort S, Acartuerk F, 2022, Fabrication of controlled trial. Lancet, 391:230–240.
three dimensional printed tablets in flexible doses: A https://doi.org/10.1016/s0140-6736(17)32137-2
comprehensive study from design to evaluation. J Drug
Deliv Sci Technol, 74:103538. 93. Burr DB, Gallant MA, 2012, Bone remodelling in
osteoarthritis. Nat Rev Rheumatol, 8:665–673.
https://doi.org/10.1016/j.jddst.2022.103538
https://doi.org/10.1038/nrrheum.2012.130
83. Saylam E, Akkaya Y, Ilhan E, et al., 2021, Levodopa-loaded
3D-printed poly (lactic) acid/chitosan neural tissue scaffold 94. Felson DT, Lawrence RC, Dieppe PA, et al., 2000,
as a promising drug delivery system for the treatment of Osteoarthritis: New insights. Part 1: The disease and its risk
Parkinson’s disease. Appl Sci Basel, 11(22):10727. factors. Ann Intern Med, 133:635–646.
https://doi.org/10.3390/app112210727 https://doi.org/10.7326/0003-4819-133-8-200010170-00016
84. Renishaw, 2020, Renishaw announces completion of clinical 95. Cross M, Smith E, Hoy D, et al., 2014, The global burden
trial extension study, using its innovative drug delivery of hip and knee osteoarthritis: estimates from the global

Volume 9 Issue 4 (2023) 256 https://doi.org/10.18063/ijb.732